Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant proteinGILLARD, Michel; CHATELAIN, Pierre; FUKS, Bruno et al.European journal of pharmacology. 2006, Vol 536, Num 1-2, pp 102-108, issn 0014-2999, 7 p.Article

Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant propertiesGILLARD, Michel; FUKS, Bruno; LECLERCQ, Marine et al.European journal of pharmacology. 2011, Vol 664, Num 1-3, pp 36-44, issn 0014-2999, 9 p.Article

[³H]linopirdine binding to rat brain membranes is not relevant for M-channel interactionWOLFF, Christian; GILLARD, Michel; FUKS, Bruno et al.European journal of pharmacology. 2005, Vol 518, Num 1, pp 10-17, issn 0014-2999, 8 p.Article

Characterization of [³H]ucb 30889 binding to synaptic vesicle protein 2A in the rat spinal cordLAMBENG, Nathalie; GILLARD, Michel; VERTONGEN, Pascale et al.European journal of pharmacology. 2005, Vol 520, Num 1-3, pp 70-76, issn 0014-2999, 7 p.Article

Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell linesFUKS, Bruno; GILLARD, Michel; MICHEL, Philippe et al.European journal of pharmacology. 2003, Vol 478, Num 1, pp 11-19, issn 0014-2999, 9 p.Article

Mitochondria permeability transition-dependent tert-butyl hydroperoxide-induced apoptosis in hepatoma HepG2 cellsPIRET, Jean-Pascal; ARNOULD, Thierry; FUKS, Bruno et al.Biochemical pharmacology. 2004, Vol 67, Num 4, pp 611-620, issn 0006-2952, 10 p.Article

Binding characteristics of [³H]ucb 30889 to levetiracetam binding sites in rat brainGILLARD, Michel; FUKS, Bruno; MICHEL, Philippe et al.European journal of pharmacology. 2003, Vol 478, Num 1, pp 1-9, issn 0014-2999, 9 p.Article

In vitro properties of 5-(benzylsulfonyl)-4-bromo-2-methyl-3(2H)-pyridazinone : A novel permeability transition pore inhibitorFUKS, Bruno; TALAGA, Patrice; HUART, Catherine et al.European journal of pharmacology. 2005, Vol 519, Num 1-2, pp 24-30, issn 0014-2999, 7 p.Article

Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activityKENDA, Benoit M; MATAGNE, Alain C; FUKS, Bruno et al.Journal of medicinal chemistry (Print). 2004, Vol 47, Num 3, pp 530-549, issn 0022-2623, 20 p.Article

Failure of GPI compounds to display neurotrophic activity in vitro and in vivoBOCQUET, Arnaud; LORENT, Geneviève; FUKS, Bruno et al.European journal of pharmacology. 2001, Vol 415, Num 2-3, pp 173-180, issn 0014-2999Article